性传播感染健康信息与监测(SIM研究):一项旨在提高梅毒治疗和随访依从性的单中心、平行、三臂随机对照试验方案
梅毒在巴西先天性和获得性病例均增加,本SIM研究为单中心三臂随机对照试验方案,计划在移动单元完成10000次梅毒快速检测,VDRL确诊患者随机分入电话、智能手机游戏或传统面对面随访三组,比较12个月随访期内治疗依从性,按意向性分析原则评估。
要点
- SIM研究计划在易达地点的移动单元完成10000次梅毒快速检测。
- VDRL确诊患者随机分入电话、智能手机游戏或传统面对面随访三组。
- 主要目的是识别提高治疗依从性最有效的随访方法,随访期12个月。
核心结论
- 若发现各组有效性存在差异,可能需要对这一患者群体的传统随访方式做出重大改变,并可能影响巴西现行卫生政策策略。
研究设计与样本
- SIM研究为单中心、平行、三臂随机对照试验方案,随访期12个月,所有分析遵循意向性分析原则。
- 计划在易达地点的移动单元完成10000次梅毒快速检测,VDRL确诊患者随机分入电话、智能手机游戏或传统面对面随访三组。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Syphilis has recently resurfaced as a significant public health problem. Since the 2000s, isolated syphilis outbreaks have increasingly occurred in North America, Europe, and Australia; in Brazil, there have been progressive increases in both congenital and acquired syphilis. There are several possible explanations, such as misdiagnosis of acquired syphilis, which could increase the number of untreated transmitters in the population; failure to initiate or complete treatment; and nontreatment of sexual partners (leading to reinfection). Mobile technologies have been successfully used to promote behavior changes and can positively impact treatment and follow-up adherence in patients with infectious diseases. The purpose of this clinical trial is to evaluate treatment and monitoring methods in patients with syphilis, including follow-up by telephone, via a game in a smartphone app, and at public health centers. METHODS: The SIM study is a single-center, randomized controlled trial with a 12-month follow-up period. The aim is to identify the most effective method of follow-up regarding patient compliance with treatment. The tests will be performed in a mobile unit in easily accessible locations. The goal is to perform 10,000 rapid tests for syphilis. Patients with a confirmed diagnosis according to VDRL tests will be randomized to one of three arms: telephone, smartphone game, or conventional in-person follow-up. All analyses will follow the intention-to-treat principle. CONCLUSION: If we find differences in effectiveness, a major change in the conventional approach for this patient population may be needed, potentially affecting current Brazilian health policy strategies. TRIAL REGISTRATION: NTC04753125 . Version 1 of protocol 1/09/2020.
引用
- Wendland EM, de Oliveira VM, Pedrotti LG, et al. Health Information and Monitoring of Sexually Transmitted Infections (SIM study): a single-center, parallel, three-arm randomized controlled trial protocol for enhancing adherence to syphilis treatment and follow-up. Trials. 2022. PMID: 35619152. doi:10.1186/s13063-022-06383-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。